Logo image
Sign in
LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
Journal article   Open access  Peer reviewed

LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Rohit Loomba, Mazen Noureddin, Kris Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal Raj Bhandari, Nadege T. Gunn, Stephen Caldwell, Zachary Goodman, …
Journal of hepatology, Vol.73, pp.S116-S117
08/2020
url
https://doi.org/10.1016/S0168-8278(20)30753-4View
Published (Version of record) Open

Metrics

4 Record Views

Details